EXAMPLES OF CONSULTATIVE ASSIGNMENTS DONE
Preparing non-clinical development strategic plans (up to early Phase II) for biotechnology and small molecule compounds; consulting client during plan execution.
Writing Pharmacology/Toxicology/ADME summary as part of the IND or NDA submissions; reviewing Investigators’ Drug Brochures; updating drug inserts.
Representing client at the FDA for non-clinical safety evaluation of drug candidates.
Conducting due-diligence evaluation for non-clinical pharmacology/toxicology/ADME of in- or out-licensing drug candidates; representing client at business discussion meetings.
Serving on an Expert Panel for safety issues at a pre-NDA approval decision stage.
Advising pharmaceutical R&D management on optimizing global drug development; evaluating operational capabilities of pathology, toxicology and experimental medicine.
Supporting pharmaceutical International/US Project Teams in non-clinical development and regulatory issues in pharmacology/toxicology/ADME; participate in toxicology International Functional Team.
Writing/reviewing non-clinical toxicology reports generated by contract laboratories.
Supervising necropsy/examining slides/writing reports/conducting pathology peer reviews in non clinical toxicity studies.
Providing pathology support for laboratory animal services/pharmacology research/ exploratory toxicology.
Serving as the principle investigator in electron microscopy non-clinical toxicity study.
Conducting special histopathologic examinations and evaluating toxicologic effects for the FDA.
Evaluating non-clinical findings (experimental and GLPs studies) of intracellular drug storage.
Providing scientific relevance to human safety for “unusual” findings in animal safety studies.
Planning strategy for regulatory registration of a veterinary therapeutic agent.
Giving seminars/lectures on non-clinical toxicological assessment of the nervous and the cardiovascular systems.
Preparing/teaching a continuing education courses on regulatory safety assessment.
Providing scientific support for health issues related to Indoor Environment Quality.
Advising on development of a software program for computing cell proliferation and promoting the product in the scientific community.
Providing scientific support in toxicology/pathology/medicine to law firms.